SA41-0207 Screening compound: 4-[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]-1-[7-(methoxymethyl)-6-methyl-2,6-diazaspiro[3.4]oct-2-yl]-1-butanone

SA41-0207 Screening compound: 4-[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]-1-[7-(methoxymethyl)-6-methyl-2,6-diazaspiro[3.4]oct-2-yl]-1-butanone
SA41-0207 Screening compound: 4-[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]-1-[7-(methoxymethyl)-6-methyl-2,6-diazaspiro[3.4]oct-2-yl]-1-butanone alternative view

Chemical Structure Depiction of ChemDiv screening compound SA41-0207
4-[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]-1-[7-(methoxymethyl)-6-methyl-2,6-diazaspiro[3.4]oct-2-yl]-1-butanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

SA41-0207

Molecular Formula

C23H32N4O5 (C23 H32 N4 O5)

Compound Name

4-[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]-1-[7-(methoxymethyl)-6-methyl-2,6-diazaspiro[3.4]oct-2-yl]-1-butanone

IUPAC name

4-[3-(34-dimethoxyphenyl)-124-oxadiazol-5-yl]-1-[7-(methoxymethyl)-6-methyl-26-diazaspiro[3.4]octan-2-yl]butan-1-one

SMILES

CN1C(COC)CC(C2)(CN2C(CCCc2nc(-c(cc3)cc(OC)c3OC)no2)=O)C1

InChI

InChI=1S/C23H32N4O5/c1-26-13-23(11-17(26)12-29-2)14-27(15-23)21(28)7-5-6-20-24-22(25-32-20)16-8-9-18(30-3)19(10-16)31-4/h8-10,17H,5-7,11-15H2,1-4H3/t17-/m0/s1

InChI Key

HARWOTVAAAOUOZ-KRWDZBQOSA-N

MDL Number (MFCD)

MFCD32236621

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

444.53

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.808

Distribution Coefficient, logD

-1.963

Water Solubility, LogSw

-2.35

Polar Surface Area

75.144

Acid Dissociation Constant (pKa)

23.08

Base Dissociation Constant (pKb)

11.17

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

60.87

SA41-0207 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

Ion Channels Focused Library (26372 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Nervous system
  • Cardiovascular
Targets:
  • Ion Channels

References: we are preparing a list of scientific research reports with SA41-0207 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound SA41-0207?
Check Price and Availability of SA41-0207, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of SA41-0207 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for SA41-0207
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for SA41-0207
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of SA41-0207 available by request